Results 191 to 200 of about 247,410 (364)
Psychiatric co-morbidity and substance abuse after gastric bypass surgery. [PDF]
Svensson CJ +4 more
europepmc +1 more source
Laparoscopic Roux-en-Y Gastric Bypass Surgery in the Obesity Center Wuerzburg – Patient Selection and Results [PDF]
Martin Fein +5 more
openalex +1 more source
Metabolic and appetitive regulation of adipocyte mass during treatment of obesity
Abstract Adipose mass is homeostatically maintained within a narrow range despite fluctuations in daily calorie intake and activity levels. Constituting an adipose mass “set point,” this homeostatic regulation includes sensing mechanisms in the form of hormones reflecting caloric intake that serve as mediators of appetitive behaviors and adipose mass ...
Jonathan Q. Purnell, Carel W. Le Roux
wiley +1 more source
DGBI symptoms are common in obesity and have the potential to exacerbate negative health outcomes. In general, the prevalence of DGBI symptoms decreases after obesity treatment, but patients can also shift from one GI symptom profile to another. ABSTRACT Background & Aims Disorders of gut‐brain interaction (DGBI) in obesity could impair health outcomes.
Esther Colomier +11 more
wiley +1 more source
Duodenal perforation in the excluded segment: twenty-five years post-Roux-en-Y gastric bypass surgery: a case report. [PDF]
Aftab N +5 more
europepmc +1 more source
Severe Ketoacidosis After One Anastomosis Gastric Bypass Surgery. [PDF]
Nevo N +5 more
europepmc +1 more source
ABSTRACT Sarcopenic obesity, characterized by the concurrent presence of excess adiposity and diminished skeletal muscle mass and function, is closely linked to frailty, chronic inflammation, and insulin resistance. The increasing prevalence of sarcopenic obesity is driven by the global aging population, widespread adoption of sedentary lifestyles, and
Michael Macleod +5 more
wiley +1 more source
Petersen's space hernia as a complication of gastric bypass surgery: a case report. [PDF]
Palacios MF +5 more
europepmc +1 more source

